Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bartkova

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Cancer Research|December 1, 1996
The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesisJ Bartkova, J Lukas, P Guldberg, et al.
Virchows Archiv : an International Journal of Pathology|September 20, 2001
p21/WAF1/Cip1 expression in invasive ductal breast carcinoma: relationship to p53, proliferation rate, and survival at 5 yearsW Domagala, M Welcker, M Chosia, et al.
FEBS Letters|March 29, 2000
Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitorsM Thullberg, J Bartkova, S Khan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?D M Barnes, J Bartkova, R S Camplejohn, et al.
British Journal of Cancer|March 1, 1991
The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancerS M O'Reilly, D M Barnes, R S Camplejohn, et al.
Cell Death & Disease|July 25, 2014
Immortalised breast epithelia survive prolonged DNA replication stress and return to cycle from a senescent-like stateA Maya-Mendoza, J M Merchut-Maya, J Bartkova, et al.
Nature|June 8, 1995
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16J Lukas, D Parry, L Aagaard, et al.
The Journal of Cell Biology|May 1, 1994
DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1J Lukas, H Müller, J Bartkova, et al.
Histopathology|February 28, 2003
The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE-A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminomaE Rajpert-De Meyts, G K Jacobsen, J Bartkova, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1996
Phenotype-related differences in the expression of D-type cyclins in human B cell-derived linesK Pokrovskaja, B Ehlin-Henriksson, J Bartkova, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Cancer Research|December 1, 1996
The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesisJ Bartkova, J Lukas, P Guldberg, et al.
Virchows Archiv : an International Journal of Pathology|September 20, 2001
p21/WAF1/Cip1 expression in invasive ductal breast carcinoma: relationship to p53, proliferation rate, and survival at 5 yearsW Domagala, M Welcker, M Chosia, et al.
FEBS Letters|March 29, 2000
Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitorsM Thullberg, J Bartkova, S Khan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?D M Barnes, J Bartkova, R S Camplejohn, et al.
British Journal of Cancer|March 1, 1991
The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancerS M O'Reilly, D M Barnes, R S Camplejohn, et al.
Cell Death & Disease|July 25, 2014
Immortalised breast epithelia survive prolonged DNA replication stress and return to cycle from a senescent-like stateA Maya-Mendoza, J M Merchut-Maya, J Bartkova, et al.
Nature|June 8, 1995
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16J Lukas, D Parry, L Aagaard, et al.
The Journal of Cell Biology|May 1, 1994
DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1J Lukas, H Müller, J Bartkova, et al.
Histopathology|February 28, 2003
The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE-A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminomaE Rajpert-De Meyts, G K Jacobsen, J Bartkova, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1996
Phenotype-related differences in the expression of D-type cyclins in human B cell-derived linesK Pokrovskaja, B Ehlin-Henriksson, J Bartkova, et al.
Pageof 7